Please ensure Javascript is enabled for purposes of website accessibility

Manning Institute of Biotechnology

Mark T. Esser is the incoming head of the University of Virginia's Manning Institute of Biotechnology. Photo courtesy UVA Health
Apr 10, 2025

U.Va. hires AstraZeneca exec to lead Manning biotech institute

Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute of Biotechnology at the University of Virginia, U.Va. announced Thursday. Esser, who will join U.Va. May 1, earned a Ph.D. in microbiology in 1998 from […]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.